These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8943576)

  • 21. Polymorphism at beta 85 and not beta 86 of HLA-DR1 is predominantly responsible for restricting the nature of the anchor side chain: implication for concerted effects of class II MHC polymorphism.
    Wu S; Gorski J
    Int Immunol; 1997 Oct; 9(10):1495-502. PubMed ID: 9352354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apparent HLA DR triplet due to the coexpression of a DRB5-encoded molecule on a DR1 haplotype.
    Gebuhrer L; Tiercy JM; Freidel AC; Labonne MP; Lambert J; Jeannet M; Betuel H
    Hum Immunol; 1992 Jun; 34(2):91-8. PubMed ID: 1429037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analysis of synthetic peptide restriction by HLA-DR alleles in T cells from human subjects, naturally sensitized by Streptococcus mutans.
    Childerstone A; Altmann D; Haron JA; Wilkinson D; Trowsdale J; Lehner T
    J Immunol; 1991 Mar; 146(5):1463-9. PubMed ID: 1993839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The N-terminal region of photocleavable peptides that bind HLA-DR1 determines the kinetics of fragment release.
    Negroni MP; Stern LJ
    PLoS One; 2018; 13(7):e0199704. PubMed ID: 29965980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides.
    Jardetzky TS; Brown JH; Gorga JC; Stern LJ; Urban RG; Strominger JL; Wiley DC
    Proc Natl Acad Sci U S A; 1996 Jan; 93(2):734-8. PubMed ID: 8570625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid HLA-DRB1 generic typing by PCR-SSP method.
    Qiu C; Zhao Y; Tao Z; Zhu X; Xu Z; Dong Y
    Chin Med Sci J; 1995 Mar; 10(1):34-7. PubMed ID: 7780115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of hydrogen bonds between major histocompatibility complex class II and the peptide N-terminus is not sufficient to form a human leukocyte antigen-DM receptive state of major histocompatibility complex class II.
    Schulze MS; Anders AK; Sethi DK; Call MJ
    PLoS One; 2013; 8(7):e69228. PubMed ID: 23976922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of polymorphic residues of human leucocyte antigen-DR molecules on the binding of human immunodeficiency virus peptides.
    Jurcevic S; Praud C; Coppin HL; Bertrand A; Ricard S; Thomsen M; Lakhdar-Ghazal F; De Preval C
    Immunology; 1996 Mar; 87(3):414-20. PubMed ID: 8778027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clip binds to HLA class II using methionine-based, allele-dependent motifs as well as allele-independent supermotifs.
    Geluk A; Van Meijgaarden KE; Drijfhout JW; Ottenhoff TH
    Mol Immunol; 1995 Sep; 32(13):975-81. PubMed ID: 7477003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complementarity and redundancy of the binding specificity of HLA-DRB1, -DRB3, -DRB4 and -DRB5 molecules.
    Texier C; Pouvelle-Moratille S; Busson M; Charron D; Ménez A; Maillère B
    Eur J Immunol; 2001 Jun; 31(6):1837-46. PubMed ID: 11433380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen.
    Rosloniec EF; Ivey RA; Whittington KB; Kang AH; Park HW
    J Immunol; 2006 Sep; 177(6):3884-92. PubMed ID: 16951351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1.
    Natarajan SK; Stern LJ; Sadegh-Nasseri S
    J Immunol; 1999 Mar; 162(6):3463-70. PubMed ID: 10092802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease.
    Inaba H; Martin W; De Groot AS; Qin S; De Groot LJ
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2286-94. PubMed ID: 16595602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.
    Chicz RM; Urban RG; Gorga JC; Vignali DA; Lane WS; Strominger JL
    J Exp Med; 1993 Jul; 178(1):27-47. PubMed ID: 8315383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
    Duyar H; Dengjel J; de Graaf KL; Wiesmüller KH; Stevanović S; Weissert R
    Immunogenetics; 2005 Apr; 57(1-2):69-76. PubMed ID: 15711804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR.
    Roche PA; Cresswell P
    J Immunol; 1990 Mar; 144(5):1849-56. PubMed ID: 2307844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
    Karp DR; Long EO
    J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic flexibility of a peptide-binding groove of human HLA-DR1 class II MHC molecules: normal mode analysis of the antigen peptide-class II MHC complex.
    Nojima H; Takeda-Shitaka M; Kurihara Y; Kamiya K; Umeyama H
    Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):923-8. PubMed ID: 12913229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of allele-specific contact sites of natural HLA-DR17 ligands.
    Malcherek G; Gnau V; Stevanovic S; Rammensee HG; Jung G; Melms A
    J Immunol; 1994 Aug; 153(3):1141-9. PubMed ID: 8027545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.